Inactive Instrument

Company Vyant Bio, Inc.

Equities

VYNT

US92942V2088

Investment Holding Companies

Business Summary

Vyant Bio, Inc. has no continuing operating activities other than the winddown and closure of its business. The Company is seeking to obtain its shareholders’ approval for the voluntary liquidation and dissolution of the Company, pursuant to a plan of liquidation and dissolution.

Number of employees: 4

Sales per Business

USD in Million2021Weight2022Weight Delta
Central Nervous System Drug
85.1 %
0 42.1 % 1 85.1 % +17.39%
Services
14.9 %
1 57.9 % 0 14.9 % -85.11%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
53.0 %
1 61.0 % 0 53.0 % -49.59%
International
47.0 %
0 39.0 % 0 47.0 % -30.09%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 01/19/01
Director/Board Member - 01/18/01
Director/Board Member 48 01/21/01
Director/Board Member 65 11/16/11

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 01/14/01
Director/Board Member 69 01/21/01
Chairman 78 30/21/30
Director/Board Member 65 11/16/11
Director/Board Member 57 01/14/01
Director/Board Member 48 01/21/01
Director/Board Member 61 01/21/01
Director/Board Member - 01/18/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,328,752 5,140,411 ( 81.22 %) 0 81.22 %

Company contact information

Vyant Bio, Inc.

2 Executive Campus 2370 State Route 70 West

08002, Cherry Hill

+

http://www.vyantbio.com
address Vyant Bio, Inc.(VYNT)
  1. Stock Market
  2. Equities
  3. VYNT Stock
  4. Company Vyant Bio, Inc.